ArticleBritish journal of clinical pharmacology2022

Concentration-QT modelling shows no evidence of clinically significant QT interval prolongation with capivasertib at expected therapeutic concentrations.

Veronika Voronova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.